Showing results (41-50 of 152) with videos related to
Sort By:
Pageof 16
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1989
Pharmacokinetic and pharmacodynamic modelling of metoprolol in rabbits with liver failureA Bortolotti, D Castelli, D Verotta, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|May 1, 1994
Semiparametric models for antagonistic drug interactionsI F Troconiz, L B Sheiner, D VerottaJournal of Natural Products|April 11, 2000
Hyperforin analogues from St. John's wort (Hypericum perforatum)L Verotta, G Appendino, J Jakupovic, et al.Journal of Pharmacokinetics and Biopharmaceutics|October 1, 1992
Building population pharmacokinetic--pharmacodynamic models. I. Models for covariate effectsJ W Mandema, D Verotta, L B SheinerBioorganic & Medicinal Chemistry Letters|January 20, 2007
In vitro antimalarial activity of hyperforin, a prenylated acylphloroglucinol. A structure-activity studyLuisella Verotta, Giovanni Appendino, Ezio Bombardelli, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2007
A mechanistic model for the sex-specific response to nalbuphine and naloxone in postoperative painSmita Kshirsagar, Robert Gear, Jon Levine, et al.The American Journal of Physiology|April 1, 1989
Semiparametric approach to pharmacokinetic-pharmacodynamic dataD Verotta, S L Beal, L B SheinerMedicinal Chemistry (Shariqah (United Arab Emirates))|June 22, 2006
Evaluation of hyperforin analogues for inhibition of 5-lipoxygenaseChristian Feisst, Dana Albert, Luisella Verotta, et al.The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditionsJ B Schwartz, D Verotta, L B SheinerBiometrics|December 1, 1995
A new method to explore the distribution of interindividual random effects in non-linear mixed effects modelsK E Fattinger, L B Sheiner, D VerottaPageof 16